Thuja Capital Overview
Thuja Capital is a leading early-stage venture capital firm dedicated to investing in the most innovative life science companies in Europe. By investing early and partnering with visionary CEOs, they strive to have a transformative impact on healthcare. They leverage deep sector expertise, entrepreneurial experience, and a strong network across academia, industry, and clinical research institutions to help build exceptional companies.
Is Thuja Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Thuja Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Thuja Capital
Investment focus
Invest in
- Baltics
- Nordics
- Western Europe
- Southern Europe
- Central Eastern Europe
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- Health Data, Healthcare Systems & Infrastructure
- MedTech & Devices
Investment role
Lead and follow
Stages
Seed, Series A
First ticket size
€500,000 - €5,000,000
Contact information
Principal
Tyler Hayes
Associate
Lisanne Blauw
Investment Analyst
Domhnall Kelly
Associate
Eleanor Price
Venture Partner
Florian Ludwig
How to approach funds like Thuja Capital
Thuja Capital values early-stage life science ventures with clinically validated innovations in therapeutics, medical devices, and digital health. Emphasize your product's clinical evidence and potential to address unmet medical needs. Highlight your team's expertise and readiness to navigate regulatory pathways, as Thuja actively supports companies through critical development milestones.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
